Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arterial thrombosis | x | ||||||||||||||||
Atrial fibrillation | x | x | x | x | x | x | x | x | |||||||||
Clotting | x | x | x | x | x | x | x | x | x | ||||||||
Coagulopathy | x | x | x | x | |||||||||||||
Deep vein thrombosis postoperative | x | x | x | x | x | ||||||||||||
Disseminated intravascular coagulation | x | x | x | x | x | x | x | x | x | ||||||||
Embolism arterial | x | x | x | x | x | x | x | x | x | ||||||||
Pulmonary embolism | x | x | x | x | x | x | x | ||||||||||
Venous thrombosis | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |